We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
-0.02%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.29T
AUM Growth
-$219M
(-0.01%)
Cap. Flow
+$31.2B
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
14.44%
Holding
4,163
New
99
Increased
2,949
Reduced
960
Closed
63
Avg Time Held
3.9
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
3.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$1.53B |
| 2 |
American Tower
AMT
|
+$1.49B |
| 3 |
McDonald's
MCD
|
+$1.13B |
| 4 |
Crown Castle
CCI
|
+$1.07B |
| 5 |
Alibaba
BABA
|
+$970M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$762M |
| 2 |
Amgen
AMGN
|
+$595M |
| 3 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$497M |
| 4 |
CPN
Calpine Corporation
CPN
|
+$468M |
| 5 |
POT
Potash Corp Of Saskatchewan
POT
|
+$427M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.91% |
| 2 | Financials | 16.33% |
| 3 | Healthcare | 12.63% |
| 4 | Industrials | 10.89% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
Parke Bancorp
PKBK
$384M
| $5.03M | ﹤0.01% |
292,381
+3,536
| +1% | +$60.3K |
2013 Q2
19 quarters
|
|
3152
STRATTEC Security
STRT
$247M
| $5.02M | ﹤0.01% |
137,973
+3,420
| +3% | +$132K |
2013 Q2
19 quarters
|
|
|
PFBI
3153
DELISTED
Premier Financial Bancorp
PFBI
| $5M | ﹤0.01% |
335,604
+10,291
| +3% | +$155K |
2013 Q2
19 quarters
|
|
|
SEAC
3154
DELISTED
Seachange International Inc
SEAC
| $4.98M | ﹤0.01% |
91,955
+12,291
| +15% | +$803K |
2013 Q2
19 quarters
|
|
|
ZYNE
3155
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $4.98M | ﹤0.01% |
572,694
-26,457
| -4% | -$285K |
2015 Q3
10 quarters
|
|
|
TESS
3156
DELISTED
Tessco Technologies Inc
TESS
| $4.98M | ﹤0.01% |
214,956
+19,583
| +10% | +$425K |
2013 Q2
19 quarters
|
|
|
ORBK
3157
DELISTED
Orbotech Ltd
ORBK
| $4.97M | ﹤0.01% |
80,014
+45,602
| +133% | +$2.5M |
2016 Q2
7 quarters
|
|
3158
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $4.97M | ﹤0.01% |
325,305
+7,474
| +2% | +$178K |
2015 Q2
11 quarters
|
|
|
LBY
3159
DELISTED
Libbey, Inc.
LBY
| $4.96M | ﹤0.01% |
1,013,260
+5,360
| +0.5% | +$36.4K |
2013 Q2
19 quarters
|
|
3160
Banco Santander
SAN
$195B
| $4.95M | ﹤0.01% |
788,161
-117,841
| -13% | -$781K |
2013 Q2
19 quarters
|
|
3161
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $4.92M | ﹤0.01% |
1,981
-12
| -0.6% | -$26.7K |
2013 Q2
19 quarters
|
|
3162
Quantum Corp
QMCO
$852M
| $4.92M | ﹤0.01% |
67,602
+7,736
| +13% | +$753K |
2013 Q2
19 quarters
|
|
3163
GSI Technology
GSIT
$163M
| $4.89M | ﹤0.01% |
660,107
+78,418
| +13% | +$632K |
2013 Q2
19 quarters
|
|
|
AREX
3164
DELISTED
Approach Resources Inc.
AREX
| $4.89M | ﹤0.01% |
1,873,070
+331,302
| +21% | +$1.02M |
2013 Q2
19 quarters
|
|
3165
Anavex Life Sciences
AVXL
$137M
| $4.88M | ﹤0.01% |
1,769,427
+35,352
| +2% | +$99.9K |
2015 Q4
9 quarters
|
|
3166
Babcock & Wilcox
BW
$739M
| $4.88M | ﹤0.01% |
111,758
-46,526
| -29% | -$2.7M |
2015 Q3
10 quarters
|
|
|
SRT
3167
DELISTED
Startek Inc.
SRT
| $4.85M | ﹤0.01% |
495,519
+38,584
| +8% | +$418K |
2013 Q2
19 quarters
|
|
3168
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $4.82M | ﹤0.01% |
760,579
-70,567
| -8% | -$584K |
2013 Q2
19 quarters
|
|
|
SPNE
3169
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $4.81M | ﹤0.01% |
474,051
+6,179
| +1% | +$63.5K |
2015 Q3
10 quarters
|
|
3170
DELISTED
Independence Contract Drilling, Inc.
ICD
| $4.8M | ﹤0.01% |
63,446
+7,609
| +14% | +$668K |
2014 Q3
14 quarters
|
|
|
GST
3171
DELISTED
Gastar Exploration Inc.
GST
| $4.77M | ﹤0.01% |
6,986,149
+383,555
| +6% | +$358K |
2013 Q2
19 quarters
|
|
3172
DELISTED
Sears Holding Corporation
SHLD
| $4.75M | ﹤0.01% |
1,779,157
-444,502
| -20% | -$1.2M |
2013 Q2
19 quarters
|
|
|
OTIC
3173
DELISTED
Otonomy, Inc.
OTIC
| $4.74M | ﹤0.01% |
1,129,656
+37,221
| +3% | +$203K |
2014 Q3
14 quarters
|
|
3174
eGain
EGAN
$146M
| $4.74M | ﹤0.01% |
595,985
-45,382
| -7% | -$301K |
2013 Q2
19 quarters
|
|
3175
QuickLogic
QUIK
$171M
| $4.72M | ﹤0.01% |
221,673
+11,409
| +5% | +$288K |
2013 Q2
19 quarters
|
|
Similar funds
Vanguard Group's Q1 2018 Portfolio in Review
As of Q1 2018, Vanguard Group held 4,163 positions worth $2.29T, down 0.01% from $2.29T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 3.9%. Vanguard Group opened 99 new positions and exited 63, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2018 buy was Nutrien: 16,386,239 shares worth $774M.
- Vanguard Group added most to Walmart Inc in Q1 2018, an estimated $1.53B increase.
- Vanguard Group's biggest Q1 2018 reduction was Amgen, cutting an estimated $595M.
- Vanguard Group fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $762M.
- Vanguard Group's ten largest holdings make up 14% of its $2.29T portfolio in Q1 2018.
- Vanguard Group opened 99 new positions and closed 63 in Q1 2018.
- Vanguard Group's portfolio value fell 0.01% quarter-over-quarter to $2.29T.
Based on Vanguard Group's 13F filing for Q1 2018, filed 15 May 2018.